Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-24

Clinical Trial Update: Ciclosporin in the Management of New Type 1 Reactions in Leprosy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 study evaluating cyclosporine for the management of Type 1 reactions in leprosy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Leprosy | Phase 2, Phase 3 | Status: COMPLETED